What is the ticker symbol for Braveheart Bio?

Braveheart Bio trades under the ticker BRVE on NASDAQ.

What sector does Braveheart Bio operate in?

Braveheart Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BRVE in a portfolio?

PortView shows BRVE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Braveheart Bio (BRVE) Stock Analysis

NASDAQHealthcareBiotechnology

$26.51+0.86%

1-year price historyRange $18.00 – $30.00

52-week range$26.51

$24.31$32.00

What Braveheart Bio does

Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.

Key metrics

Market cap

$1.87B

Beta

0.00

50-day avg

$27.36

200-day avg

$27.36

52-week high

$32.00

52-week low

$24.31

CEO

Travis Murdoch

ETFs linked to BRVE

Broad-market and Healthcare sector ETFs an investor holding Braveheart Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BRVE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BRVE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Braveheart Bio?: Braveheart Bio trades under the ticker BRVE on NASDAQ.
Which exchange is BRVE listed on?: BRVE is listed on NASDAQ.
What sector does Braveheart Bio operate in?: Braveheart Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BRVE in a portfolio?: PortView shows BRVE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.